VBIO VITA BIOLOGICAL CP
VITA BIOLOGICAL CP (VBIO) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Where they traded
Last open-market purchase: April 15, 2026 , by Bolton Sheryle .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Bolton Sheryle | Director | Buy | 10,000 | $1.04 | $10.4K | 10,000 | |
| Valauri Christina Rizopoulos | Director | Buy | 19,000 | $0.95 | $18.0K | 19,000 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.